These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9864931)

  • 21. Kinetic of regulatory CD25high and activated CD134+ (OX40) T lymphocytes during acute and chronic graft-versus-host disease after allogeneic bone marrow transplantation.
    Sanchez J; Casaño J; Alvarez MA; Roman-Gomez J; Martin C; Martinez F; Gomez P; Serrano J; Herrera C; Torres A
    Br J Haematol; 2004 Sep; 126(5):697-703. PubMed ID: 15327522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune regulation of T lymphocyte by a newly characterized human umbilical cord blood stem cell.
    Zhao Y; Huang Z; Qi M; Lazzarini P; Mazzone T
    Immunol Lett; 2007 Jan; 108(1):78-87. PubMed ID: 17161871
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunological properties of umbilical cord blood-derived mesenchymal stromal cells.
    Oh W; Kim DS; Yang YS; Lee JK
    Cell Immunol; 2008 Feb; 251(2):116-23. PubMed ID: 18495100
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential effect of IL-15 and IL-2 on survival of phytohemagglutinin-activated umbilical cord blood T cells.
    Lin SJ; Cheng PJ; Hsiao SS; Lin HH; Hung PF; Kuo ML
    Am J Hematol; 2005 Oct; 80(2):106-12. PubMed ID: 16184573
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of interleukin-15 on alloreactivity in umbilical cord blood.
    Lin SJ; Cheng PJ; Yan DC; Lee PT; Hsaio HS
    Transpl Immunol; 2006 Aug; 16(2):112-6. PubMed ID: 16860714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Naive human T-cells become non-responsive towards anti-TNFalpha (infliximab) treatment in vitro if co-stimulated through CD28.
    Gunnlaugsdottir B; Skaftadottir I; Ludviksson BR
    Scand J Immunol; 2008 Dec; 68(6):624-34. PubMed ID: 19000096
    [TBL] [Abstract][Full Text] [Related]  

  • 27. TRGV and TRDV repertoire distribution and clonality of T cells from umbilical cord blood.
    Li Y; Chen S; Yang L; Li B; Chan JY; Cai D
    Transpl Immunol; 2009 Jan; 20(3):155-62. PubMed ID: 19013241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Umbilical cord blood as a source of stem cells].
    Bojanić I; Golubić Cepulić B
    Acta Med Croatica; 2006 Jun; 60(3):215-25. PubMed ID: 16933834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppressor function of umbilical cord blood-derived CD4+CD25+ T-regulatory cells exposed to graft-versus-host disease drugs.
    Porter SB; Liu B; Rogosheske J; Levine BL; June CH; Kohl VK; Wagner JE; Miller JS; Blazar BR
    Transplantation; 2006 Jul; 82(1):23-9. PubMed ID: 16861937
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of alloreactive T lymphocytes in fetal liver: implications for fetal hematopoietic stem cell transplantation.
    Renda MC; Fecarotta E; Dieli F; Markling L; Westgren M; Damiani G; Jakil C; Picciotto F; Maggio A
    Bone Marrow Transplant; 2000 Jan; 25(2):135-41. PubMed ID: 10673670
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intracellular cytokine profile of cord blood T-, and NK- cells and monocytes.
    Krampera M; Tavecchia L; Benedetti F; Nadali G; Pizzolo G
    Haematologica; 2000 Jul; 85(7):675-9. PubMed ID: 10897117
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T lymphocytes determine the development of xeno GVHD and of human hemopoiesis in NOD/SCID mice following human umbilical cord blood transplantation.
    Verlinden SF; Mulder AH; de Leeuw JP; van Bekkum DW
    Stem Cells; 1998; 16 Suppl 1():205-17. PubMed ID: 11012164
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced expression of the interleukin-2-receptor gamma chain on cord blood lymphocytes: relationship to functional immaturity of the neonatal immune response.
    Zola H; Fusco M; Weedon H; Macardle PJ; Ridings J; Roberton DM
    Immunology; 1996 Jan; 87(1):86-91. PubMed ID: 8666440
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The graft content of donor T cells expressing gamma delta TCR+ and CD4+foxp3+ predicts the risk of acute graft versus host disease after transplantation of allogeneic peripheral blood stem cells from unrelated donors.
    Pabst C; Schirutschke H; Ehninger G; Bornhäuser M; Platzbecker U
    Clin Cancer Res; 2007 May; 13(10):2916-22. PubMed ID: 17504991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-2 production by cord blood lymphocytes stimulated with mitogen and in the mixed leukocyte culture.
    Hauser GJ; Zakuth V; Rosenberg H; Bino T; Spirer Z
    J Clin Lab Immunol; 1985 Jan; 16(1):37-40. PubMed ID: 3156997
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of activation antigens on lymphocyte surface and circulating platelet-leukocyte aggregates in ischaemic heart disease.
    Czyz A; Kołacz E; Angerer D; Zawilska K
    Kardiol Pol; 2005 Mar; 62(3):189-200; discussion 201. PubMed ID: 15830013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of immunocompetent lymphocytes in vivo from murine umbilical cord blood cells.
    Oikawa A; Ito K; Seguchi H; Okabe M; Migishima F; Eshima K; Azuma S; Song SY; Kaneko T; Shinohara N
    Transplantation; 2007 Jul; 84(1):23-30. PubMed ID: 17627233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ex vivo soluble fas ligand treatment of donor cells to selectively reduce murine acute graft versus host disease.
    Georgantas RW; Bohana-Kashtan O; Civin CI
    Transplantation; 2006 Aug; 82(4):471-8. PubMed ID: 16926590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inability of activated cord blood T lymphocytes to perform Th1-like and Th2-like responses: implications for transplantation.
    D'Arena G; Musto P; Cascavilla N; Minervini MM; Di Giorgio G; Maglione A; Carotenuto M
    J Hematother Stem Cell Res; 1999 Aug; 8(4):381-5. PubMed ID: 10634175
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.